THESEUS PHARMACEUTICALS INC (THRX)
US88369M1018 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -56.62M | -50.61M | -27.31M | -12.00M | -7.18M | |||
| Depreciation Amortization | 80.00K | 50.00K | 0.00 | 0.00 | 0.00 | |||
| Change In Working Capital | -2.00M | 6.55M | -4.25M | 930.00K | -180.00K | |||
| Other non cash items | 8.89M | 11.06M | 4.36M | 6.21M | 2.55M | |||
| OPERATING CASH FLOW | -49.64M | -32.95M | -27.19M | -4.85M | -4.81M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -80.00K | -460.00K | N/A | N/A | N/A | |||
| Other Investing Activity | -68.68M | -116.84M | 0.00 | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | -68.76M | -117.29M | 0.00 | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 49.74M | 180.00K | 267.53M | 11.99M | 2.99M | |||
| Other Financing Activity | N/A | 0.00 | -3.75M | N/A | N/A | |||
| FINANCING CASH FLOW | 49.74M | 180.00K | 263.78M | 11.99M | 2.99M | |||
| CHANGE IN CASH | -68.66M | -150.06M | 236.59M | 7.14M | -1.82M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -49.64M | -32.95M | -27.19M | -4.85M | -4.81M | |||
| Capital Expenditure | -80.00K | -460.00K | N/A | N/A | N/A | |||
| FREE CASH FLOW | -49.72M | -33.41M | -27.19M | -4.85M | -4.81M | |||
All data in USD